Publication Name	World Journal of Cardiology
Manuscript ID	60143
Country	United States

Received	2020-10-20 00:32
Peer-Review Started	2020-10-20 00:33
To Make the First Decision
Return for Revision	2020-12-24 19:02
Revised	2021-01-04 16:45
Second Decision	2021-02-22 03:33
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-03-08 06:20
Articles in Press	2021-03-08 06:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-03-15 01:50
Publish the Manuscript Online	2021-04-21 09:34

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Evidence-Based Medicine
Article Title	Challenges in managing ST elevation myocardial infarction during the COVID-19 pandemic
Manuscript Source	Unsolicited Manuscript
All Author List	Megan Smith, Aniruddha Singh, Douglas McElroy, Shilpi Mittal and Richard Pham
Funding Agency and Grant Number
Corresponding Author	Aniruddha Singh, FACC, MBBS, Assistant Professor, Department of Cardiology, University of Kentucky College of Medicine, 399 US 31W Bypass, Bowling Green, KY 42101, United States. aniruddha.singh@uky.edu
Key Words	COVID-19; ST elevation myocardial infarction; First medical contact to balloon; Major adverse cardiac events; Cardiac arrest; Death
Core Tip	The coronavirus disease 2019 (COVID-19) pandemic has affected every aspect of healthcare and has created multiple challenges in treatment of time sensitive conditions like ST elevation myocardial infarction (STEMI). We aimed to assess the behavior of presentation and outcomes of all the STEMI admissions at our facility between March 16, 2020 and August 31, 2020. We found a significantly delay from symptom onset to first medical contact in the COVID-19 group which likely resulted in significantly higher in-hospital major adverse cardiac events (MACE) and MACE at 14 d in this cohort.
Publish Date	2021-04-21 09:34
Citation	Smith M, Singh A, McElroy D, Mittal S, Pham R. Challenges in managing ST elevation myocardial infarction during the COVID-19 pandemic. World J Cardiol 2021; 13(4): 76-81
URL	https://www.wjgnet.com/1949-8462/full/v13/i4/76.htm
DOI	https://dx.doi.org/10.4330/wjc.v13.i4.76

Full Article (PDF)	WJC-13-76.pdf
Full Article (Word)	WJC-13-76.docx
PRISMA 2009 Checklist	60143-PRISMA-2009-Checklist-revision.pdf
Manuscript File	60143_Auto_Edited_LM.docx
Answering Reviewers	60143-Answering reviewers.pdf
Audio Core Tip	60143-Audio core tip.m4a
Biostatistics Review Certificate	60143-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	60143-Conflict-of-interest statement.pdf
Copyright License Agreement	60143-Copyright license agreement.pdf
Peer-review Report	60143-Peer-review(s).pdf
Scientific Misconduct Check	60143-Bing-Fan JR-1.png
Scientific Misconduct Check	60143-Bing-Fan JR-2.png
Scientific Misconduct Check	60143-Scientific misconduct check.pdf
Scientific Editor Work List	60143-Scientific editor work list.pdf